Pete Batra to Nasal Cavity
This is a "connection" page, showing publications Pete Batra has written about Nasal Cavity.
Connection Strength
1.205
-
Prevalence of metabolic bone disease among chronic rhinosinusitis patients treated with oral glucocorticoids. Am J Rhinol Allergy. 2010 May-Jun; 24(3):215-9.
Score: 0.354
-
Leiomyosarcoma of the sinonasal tract: report of a case. Otolaryngol Head Neck Surg. 2001 Dec; 125(6):663-4.
Score: 0.197
-
The impact of levels of particulate matter with an aerodynamic diameter smaller than 2.5 ?m on the nasal microbiota in chronic rhinosinusitis and healthy individuals. Ann Allergy Asthma Immunol. 2021 02; 126(2):195-197.
Score: 0.183
-
Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma. Int Forum Allergy Rhinol. 2021 01; 11(1):58-64.
Score: 0.179
-
Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures. World Neurosurg. 2016 06; 90:1-5.
Score: 0.132
-
Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg. 2008 Apr; 138(4):452-8.
Score: 0.077
-
Ossifying fibroma of the nose and paranasal sinuses. Int Forum Allergy Rhinol. 2013 Feb; 3(2):161-8.
Score: 0.026
-
Minimally invasive endoscopic endonasal management of skull base cholesterol granulomas. World Neurosurg. 2012 Dec; 78(6):683-8.
Score: 0.025
-
The prevalence of human papilloma virus infection in sinonasal inverted papilloma specimens classified by histological grade. Am J Rhinol. 2007 Nov-Dec; 21(6):664-9.
Score: 0.019
-
Inflammation and the pathogenesis of inverted papilloma. Am J Rhinol. 2004 Mar-Apr; 18(2):65-74.
Score: 0.014